A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Sophia Umansky, the 25-year-old daughter of Kyle Richards, is reacting to backlash over her use of a weight-loss drug, ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Zepbound, Mounjaro, and Ozempic can be used for weight loss. But the Food and Drug Administration (FDA) has only approved Zepbound for weight loss. Mounjaro and Ozempic are FDA approved to help ...

Mounjaro and Zepbound are brand-name medications that contain the active ingredient tirzepatide. Zepbound is prescribed to help with weight loss in certain adults. Mounjaro is prescribed to help ...

To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 ...

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.

Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...